Search Articles
BOSTON – Aveo Pharmaceuticals and its board misrepresented the prospects of the cancer drug tivozanib, and the share price dropped precipitously when the truth came out, a class action claims in Federal Court
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.